Complete resection of submucosal invasive colorectal cancer (SICC) showing favorable histology is regarded as curative. We report on two cases of SICC showing recurrence within 5 years despite complete resection. The first patient was a 68-year-old woman with well differentiated rectal adenocarcinoma invading the superficial submucosa, which recurred after 4.7 years. The second patient was a 53-year-old man with pT1N0 moderately differentiated colonic adenocarcinoma. He developed widespread tumor recurrence after 3.9 years. Retrospective pathologic review of the original tumors showed multiple foci of tumor budding at the invasive front. Immunohistochemical staining for D2-40 of deeper levels of the paraffin blocks showed rare foci of small lymphatic invasion. Tumor budding at the invasive front may be an important indicator for SICC aggressiveness or may reflect early lymphatic invasion. More aggressive pathologic examination and follow-up is required for patients with SICC showing tumor budding, even in the absence of unfavorable histologic findings.
Recent advances in endoscopic instrumentation and techni ques have led to a marked increase in the detection and endo scopic resection of early colorectal carcinomas. 1 Although endo scopic complete resection of early colorectal cancer is currently accepted as curative therapy due to the relatively low risk of lymph node metastasis, 2, 3 about 10% of patients with submu cosal invasive colorectal carcinoma (SICC) have synchronous metastases to regional lymph nodes. 2, 4 It is therefore necessary to stratify patients with SICC into lowrisk and highrisk groups to determine the risks of lymph node metastasis 5 and to elect proper additional management. The pathological features asso ciated with lymph node metastasis in patients with SICC in clude poor differentiation, deep invasion into the submucosal layer, and lymphatic channel invasion. 3, 6, 7 More recently, tumor budding has been shown to reflect the biologic aggressiveness of colorectal cancers. Herein, we describe two patients with small SICC and tumor budding, resulting in adverse outcomes within 5 years, despite favorable tumor histology and complete resec tion.
CASE REPORTS
Case 1 was a 68yearold female patient who was admitted for further treatment of an incidentally detected rectal polyp. Colonoscopic examination (Fig. 1A) showed a 2 cmsized semi pedunculated polyp, 7 cm from the anal verge. A biopsy showed an adenocarcinoma with a background of tubulovillous adeno ma. Since preoperative computed tomography (CT) showed no evidence of lymph node or distant metastasis, she underwent transanal endoscopic microsurgery with full thickness of exci (Fig. 1B) . Since no lymph nodes were included within the perirectal fat, the pathologic stage was pT1NX. The nearest safety margin to carcinoma was 1.3 cm (deep margin). There was no definitive evidence of lym phatic invasion at first pathologic diagnosis, and she therefore received no additional therapy. In April 2008, an abdominal CT performed during routine followup revealed a 2 cmsized nodular lesion in her perirectal fat ( Fig. 2A) . Anterior resection was performed, and histologic examination showed that this tumor, which involved the perirectal adipose tissue with no me tastasis out of 15 regional lymph nodes (rpT0N1c), was com patible with a recurrence of the previous rectal cancer (Fig. 2B) . Case 2 was a 53yearold male patient with tenesmus that had undergone a colonoscopy, which revealed a 1 cmsized flat elevated lesion with central depression in the sigmoid colon, 25 cm from the anal verge (Fig. 3A) . He underwent anterior resec tion in March 2004, and histologic examination showed that the tumor was a 5 mmsized, moderately differentiated adeno carcinoma invading the submucosa (sm3) (Fig. 3B ). The depth of submucosal invasion was 2.5 mm and the safety margin was at least 3 cm. No metastases were detected out of six pericolic lymph nodes, and the patient did not receive any adjuvant treat ment. In February 2008, the patient developed widespread re currence of the cancer ( resection of the small intestine. Pathologic examination revealed a recurrent adenocarcinoma extended to the periureteral soft tissue and multiple metastases to the small intestine, regional and paraaortic lymph nodes (rpT4N2bM1b) (Fig. 4B) . Retrospective pathologic review of the two primary carcino mas showed tumor buddings, defined as multiple foci of a sin gle cancer cell and/or a micronest composed of several tumor cells, at the invasive front of both primary tumors (Fig. 5) . A magnification of ×400 showed more than 10 foci in both pri mary tumors. In addition, small endolymphatic tumor emboli were detected only after deeper cutting of the paraffin blocks in both cases. These minute lymphatic invasion were not observed on the orginial hematoxylin and eosin slides. In both patients, the presence of tumor budding and lymphatic invasion was con firmed by immunohistochemical assays for cytokeratin and D2 40, respectively (Fig. 6) . Immunohistochemical staining was performed using a mouse monoclonal antibody for cytokeratin (1:500, Dako, Glostrup, Denmark) and D240 (1:200, Dako).
DISCUSSION
Complete endoscopic resection of intramucosal carcinomas in the colorectum is regarded as curative, as there is no risk of lym ph node metastasis. 2, 8 In contrast, lymph node metastasis is present in 612% of patients with SICC. Positive lymph node status has been reported to be the only significant independent predictor of 5year cancer specific survival and 5year disease free survival in patients with pT1 and pT2 colorectal cancers. The standard of care for nodepositive colorectal cancer patients is adjuvant chemotherapy based on 5flourouracil regimens. 10 Therefore, it is critical to evaluate the likelihood of lymph node metastasis in SICC. Poorly differentiated histology, presence of deep submucosal invasion, and lymphatic invasion are predic tors of lymph node metastasis in patients with T1 colorectal cancer. 3, 6, 7 Most T1 lesions without adverse pathologic features can be locally excised because the risks of local recurrence and lymph node metastasis are very low. However, a T1 lesion with unfavorable histologic features has a high risk of local recurrence and lymph node metastasis, whether metachronous or synchro nous, indicating the need for additional treatment, 2 since the prognosis is worse for patients who undergo additional surgery after local recurrence or lymph node metastasis.
Tumor budding, or the presence of isolated single tumor cells or small cell clusters (up to 4 cells) scattered in the stroma at the invasive tumor margins, has been considered a malignant characteristic of colorectal carcinomas. 11, 12 Tumor budding is observed in many colorectal carcinomas and has been reported to be a useful predictor of patient outcome 13, 14 and lymph node metastasis 6, 7, 12, 13, 15 in T1 colorectal cancer. Rectal cancer patients having a tumor budding intensity of >10 foci within a micro scopic field of ×250 had lower 5year survival rates than pa tients with tumor budding intensity of <10. Moreover, high grade "tumor budding activity," defined as 10 or more foci in a microscopic field of ×200, has been closely associated with lym phatic involvement and lymph node metastasis in SICC. 16 Im munophenotypically, loss of Ecadherin in budding cells of col orectal cancers has been reported, with loss of Ecadherin within the main tumor body being significantly associated with tumor budding. 17 Both patients described here had tumors with moderate to well differentiated histology and safety margins were sufficient for complete resection. However, recurrent disease developed within relatively short intervals. In the first patient, tumor re currence without lymph node metastasis was observed 4.7 years after local tumor excision. In the second patient, both locore gional and systemic recurrences were observed 3.9 years after surgical resection, although lymph node metastasis was not identified in the primary tumor. Since a study of endoscopical lyresected SICC demonstrated that recurrent primary cancers were significantly associated with poorly differentiated histolo gy, 18 we believed that other factors may have contributed to disease recurrence in these 2 patients. A thorough retrospective histologic review revealed frequent tumor budding from both tumors. Lymphatic channel permeation was not initially appar ent on hematoxylin and eosin staining alone but was detected only after deeper cutting of the paraffin blocks and additional immunohistochemical assays. Similar to our patients was a pa tient with a submucosal invasive colon cancer of the peduncu lated type, who developed lung metastasis 6 years after curative endoscopic polypectomy. 19 The lesion was a 1 cmsized, well differentiated adenocarcinoma showing tumor budding in the invasive front without lymphatic invasion, suggesting that tu mor budding may be a significant prognostic factor for cancer recurrence and distant metastasis. Moreover, tumor budding may be closely associated with lymphatic channel involvement and lymph node metastasis. Although lymphatic invasion is re garded as an important prognostic factor for patients with SICC, lymphatic invasion may be subjective and be overestimated or underestimated due to retraction artifacts related to tissue pro cessing for paraffin blocks. 20 In contrast to angiolymphatic in vasion, detection of tumor budding is more objective. More over, tumor budding may reflect early lymphatic invasion, even in the absence of definite lymphatic invasion. Consequently, meticulous pathologic examination is needed to detect tumor budding and angiolymphatic invasion in patients with SICC. Furthermore, immunohistochemical staining for D240 and cytokeratin may be helpful in detecting tumor budding and lymphatic channel permeation.
To our knowledge, this is the first report of cases in Korea of SICC showing tumor budding with advanced recurrences. Mul tiple tumor budding at the invasive front may predict tumor aggressiveness in SICC. Further pathologic examination for lym phatic invasion such as deeper section or immunohistochemisty is needed in cases with SICC that have frequent tumor budding in which lymphatic invasion is not seen in the original hema toxylin and eosin slides. Besides, more aggressive followup is necessary for SICC patients showing tumor budding, even in the absence of unfavorable histologic findings. Other supple mentary treatment measures, such as adjuvant chemotherapy, may be required to prevent recurrence and metastasis in these patients.
